ATE113651T1 - Rekonstituierte tumoren, herstellungsverfahren und zusammensetzung für ihre anwendung. - Google Patents

Rekonstituierte tumoren, herstellungsverfahren und zusammensetzung für ihre anwendung.

Info

Publication number
ATE113651T1
ATE113651T1 AT88403371T AT88403371T ATE113651T1 AT E113651 T1 ATE113651 T1 AT E113651T1 AT 88403371 T AT88403371 T AT 88403371T AT 88403371 T AT88403371 T AT 88403371T AT E113651 T1 ATE113651 T1 AT E113651T1
Authority
AT
Austria
Prior art keywords
tumours
composition
application
manufacturing process
reconstituted
Prior art date
Application number
AT88403371T
Other languages
English (en)
Inventor
Claire Lugassy
Jean-Paul Escande
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Elf filed Critical Sanofi Elf
Application granted granted Critical
Publication of ATE113651T1 publication Critical patent/ATE113651T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/30—Coculture with; Conditioned medium produced by tumour cells

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
AT88403371T 1987-12-31 1988-12-30 Rekonstituierte tumoren, herstellungsverfahren und zusammensetzung für ihre anwendung. ATE113651T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8718495A FR2625511B1 (fr) 1987-12-31 1987-12-31 Procede d'obtention in vitro de tissus reconstitues

Publications (1)

Publication Number Publication Date
ATE113651T1 true ATE113651T1 (de) 1994-11-15

Family

ID=9358536

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88403371T ATE113651T1 (de) 1987-12-31 1988-12-30 Rekonstituierte tumoren, herstellungsverfahren und zusammensetzung für ihre anwendung.

Country Status (6)

Country Link
EP (1) EP0328839B1 (de)
JP (1) JPH0272870A (de)
AT (1) ATE113651T1 (de)
DE (1) DE3852022D1 (de)
FR (1) FR2625511B1 (de)
PT (1) PT89357B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0499932A1 (de) * 1991-02-16 1992-08-26 W.R. Grace & Co.-Conn. Tumorzellmasse, die Tumorzellen und Normalzellen enthält, und ihre Herstellung
ES2271994T3 (es) * 1997-05-02 2007-04-16 Gen-Probe Incorporated Hibridacion en dos pasos y captura de un polinucleotido.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6133593B2 (de) * 1978-12-26 1986-08-02 Massachusetts Inst Technology
FR2610006B1 (fr) * 1987-01-22 1990-03-30 Sanofi Sa Procede de reconstitution in vitro de tumeurs

Also Published As

Publication number Publication date
DE3852022D1 (de) 1994-12-08
PT89357B (pt) 1995-03-01
EP0328839A1 (de) 1989-08-23
FR2625511B1 (fr) 1990-05-18
FR2625511A1 (fr) 1989-07-07
JPH0272870A (ja) 1990-03-13
EP0328839B1 (de) 1994-11-02
PT89357A (pt) 1989-12-29

Similar Documents

Publication Publication Date Title
RO93650B (ro) Procedeu pentru obtinerea unei polipeptide umane fiziologic activa
EP0892849A4 (de) Process zur verwendung des obese-gens und seines genprodukts zur stimulierung der entwicklung von haemotopoietischen zellen
FI92258B (fi) Onkostatiini-A:n käyttö diagnostisessa menetelmässä
MX9101913A (es) Derivados de quinazolinas para potenciar la actividad antitumoral
ATE199261T1 (de) Hybride immunglobuline
ES8801896A1 (es) Procedimiento para preparar derivados de urea
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
CA2267651A1 (en) Method of stimulating growth of melanocyte precursor cells with stem cell factor polypeptide
ES8800987A1 (es) Metodo de produccion del factor viii:c humano
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
DE3884778D1 (de) Feine Polierzusammensetzung für Plaketten.
DE3581578D1 (de) Antikoerper, herstellung und verwendung.
Miller et al. Keratinocyte stem cells of cornea, skin and hair follicle: common and distinguishing features
NO971341L (no) Promoter for reseptor tyrosinkinase TIE
HUP0400697A2 (hu) Elcsendesített anti-CD28 ellenanyagok és használatuk
DE3887194D1 (de) Antitumor-Platinkomplexe, deren Herstellung und deren therapeutische Verwendung.
PL326236A1 (en) Novel compounds - derivatives of sulphonylpyrimidine exhibiting anticarcinogenous effect and method of obtaining them
Brouty‐Boyé et al. Fetal myofibroblast‐like cells isolated from post‐radiation fibrosis in human breast cancer
ATE113651T1 (de) Rekonstituierte tumoren, herstellungsverfahren und zusammensetzung für ihre anwendung.
IT1095579B (it) Procedimento per la produzione di particelle di colorante idrosolubili,resistenti all'usura,che non impolverano e che sono solubili in acqua
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
MX204007A (es) Cuerpos de ceramica y su preparacion
Smith et al. A new creativity test.
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
ES2080954T3 (es) Uso de beta-aletina en cultivos de celulas y en terapia.

Legal Events

Date Code Title Description
EEFA Change of the company name
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties